Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Sophie Viaud, Fabiana Saccheri, Grégoire Mignot, et al.
Science (2013) Vol. 342, Iss. 6161, pp. 971-976
Open Access | Times Cited: 1776

Showing 26-50 of 1776 citing articles:

Cancer and the microbiota
Wendy S. Garrett
Science (2015) Vol. 348, Iss. 6230, pp. 80-86
Open Access | Times Cited: 1096
Inflammation and cancer: advances and new agents
Shanthini M. Crusz, Frances R. Balkwill
Nature Reviews Clinical Oncology (2015) Vol. 12, Iss. 10, pp. 584-596
Closed Access | Times Cited: 1058
Homeostatic Immunity and the Microbiota
Yasmine Belkaid, Oliver J. Harrison
Immunity (2017) Vol. 46, Iss. 4, pp. 562-576
Open Access | Times Cited: 1018
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Lorenzo Galluzzi, Juliette Humeau, Aitziber Buqué, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 12, pp. 725-741
Closed Access | Times Cited: 992
Gut microbiota in colorectal cancer: mechanisms of action and clinical applications
Sunny H. Wong, Jun Yu
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 11, pp. 690-704
Closed Access | Times Cited: 973
The microbiome, cancer, and cancer therapy
Beth A. Helmink, Md Abdul Wadud Khan, Amanda Hermann, et al.
Nature Medicine (2019) Vol. 25, Iss. 3, pp. 377-388
Closed Access | Times Cited: 958
Cellular Senescence: Aging, Cancer, and Injury
Arianna Calcinotto, Jaskaren Kohli, Elena Zagato, et al.
Physiological Reviews (2019) Vol. 99, Iss. 2, pp. 1047-1078
Open Access | Times Cited: 956
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Lukas F. Mager, Regula Burkhard, Nicola Pett, et al.
Science (2020) Vol. 369, Iss. 6510, pp. 1481-1489
Closed Access | Times Cited: 931
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt, Marie Vétizou, Romain Daillère, et al.
Immunity (2016) Vol. 44, Iss. 6, pp. 1255-1269
Open Access | Times Cited: 929
Impacts of Gut Bacteria on Human Health and Diseases
Yu-Jie Zhang, Sha Li, Ren‐You Gan, et al.
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 4, pp. 7493-7519
Open Access | Times Cited: 896
The microbiome and human cancer
Gregory D. Sepich‐Poore, Laurence Zitvogel, Ravid Straussman, et al.
Science (2021) Vol. 371, Iss. 6536
Open Access | Times Cited: 872
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
Krista Dubin, Margaret K. Callahan, Boyu Ren, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 864
A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future
Khashayar Esfahani, Liya Roudaia, Najwa Buhlaiga, et al.
Current Oncology (2020) Vol. 27, Iss. 12, pp. 87-97
Open Access | Times Cited: 794
Towards a more comprehensive concept for prebiotics
Laure B. Bindels, Nathalie M. Delzenne, Patrice D. Cani, et al.
Nature Reviews Gastroenterology & Hepatology (2015) Vol. 12, Iss. 5, pp. 303-310
Closed Access | Times Cited: 787
Microbiota: a key orchestrator of cancer therapy
Soumen Roy, Giorgio Trinchieri
Nature reviews. Cancer (2017) Vol. 17, Iss. 5, pp. 271-285
Closed Access | Times Cited: 787
Gut microbiota modulation of chemotherapy efficacy and toxicity
James L. Alexander, Ian D. Wilson, Julian Teare, et al.
Nature Reviews Gastroenterology & Hepatology (2017) Vol. 14, Iss. 6, pp. 356-365
Closed Access | Times Cited: 764
The Human Microbiota in Health and Disease
Baohong Wang, Mingfei Yao, Longxian Lv, et al.
Engineering (2017) Vol. 3, Iss. 1, pp. 71-82
Open Access | Times Cited: 757
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease
Simone Becattini, Ying Taur, Eric G. Pamer
Trends in Molecular Medicine (2016) Vol. 22, Iss. 6, pp. 458-478
Open Access | Times Cited: 744
Microbes, Microbiota, and Colon Cancer
Cynthia L. Sears, Wendy S. Garrett
Cell Host & Microbe (2014) Vol. 15, Iss. 3, pp. 317-328
Open Access | Times Cited: 738
The Basis of Oncoimmunology
Karolina Palucka, Lisa M. Coussens
Cell (2016) Vol. 164, Iss. 6, pp. 1233-1247
Open Access | Times Cited: 738
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Romain Daillère, Marie Vétizou, Nadine Waldschmitt, et al.
Immunity (2016) Vol. 45, Iss. 4, pp. 931-943
Open Access | Times Cited: 736
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
Lisa Derosa, Matthew D. Hellmann, Marco Spaziano, et al.
Annals of Oncology (2018) Vol. 29, Iss. 6, pp. 1437-1444
Open Access | Times Cited: 727
Translocation of a gut pathobiont drives autoimmunity in mice and humans
Sílvio M. Vieira, Michael Hiltensperger, Varun Kumar, et al.
Science (2018) Vol. 359, Iss. 6380, pp. 1156-1161
Open Access | Times Cited: 705
Microenvironmental regulation of therapeutic response in cancer
Florian Klemm, Johanna A. Joyce
Trends in Cell Biology (2014) Vol. 25, Iss. 4, pp. 198-213
Open Access | Times Cited: 693
Immunity, inflammation, and cancer: an eternal fight between good and evil
Shabnam Shalapour, Michael Karin
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3347-3355
Open Access | Times Cited: 629

Scroll to top